The investigation into the OPG modulatory pathways that can exert alterations in the tumorigenesis of breast cancer in this review allows for the exploration of potential therapeutic opportunities in the treatment of breast cancer. The gene discussed is TNFRSF11B; the disease is breast carcinoma.